This clearly requires investigation, given the protection afforded by melatonin against the oligomerization and damage caused by amylin in pancreatic β-cells, and may parallel recent work indicating the role of suppressed astrocyte melatonergic pathway in the accumulation of amyloid-β in dementia [97]. The gene discussed is IAPP; the disease is dementia.